High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

Gregory G. Schwartz, Bernard R. Chaitman, Jeffrey J. Goldberger, Michael Messig

Research output: Contribution to journalArticle

21 Scopus citations

Fingerprint Dive into the research topics of 'High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial'. Together they form a unique fingerprint.

Medicine & Life Sciences